Table 1.
This summary of all tumors included in the analysis over a 10-year period is split according to the diagnoses of the WHO classification.
| Soft Tissue | 628 | Bone | 339 |
|---|---|---|---|
| Adipocytic | 258 | Chondrogenic | 141 |
| Fibroblastic/myofibroblastic | 97 | Osteogenic | 90 |
| Undifferentiated/unclassified sarcoma | 82 | Tumors of undefined neoplastic nature | 45 |
| Tumors of uncertain differentiation | 71 | Osteoclastic giant cell rich | 24 |
| Nerve sheath tumors | 49 | Ewing | 18 |
| Fibro-histiocytic tumors | 21 | Notochordal tumors | 7 |
| Vascular tumors of soft tumors | 14 | Undifferentiated high-grade pleomorphic sarcoma | 4 |
| Smooth muscle tumors | 19 | Fibrohistiocytic | 3 |
| Chondro-osseous tumors | 10 | Fibrogenic | 2 |
| Pericytic tumors | 4 | Myogenic, lipogenic, epithelial tumors | 2 |
| Skeletal muscle tumors | 4 | Tumor syndromes | 2 |
| Vascular tumors | 1 | ||
| Non-neoplastic/simulator | 62 | ||
| Metastasis | 44 | ||
| Lymphoma myeloma leukemia | 12 | ||
| Sequelae of prior therapy | 8 | ||